Conferences
SUO 2017: National Trends in the Management of Patients with Positive Surgical Margin at the Time of Radical Prostatectomy
December 1, 2017
SUO 2017: Association Between Androgen-Deprivation Therapy And Non-Prostate Cancer Mortality Among Men With Non-Metastatic Prostate Cancer
December 1, 2017
SUO 2017: Does MPMRI Perform Differently in Men Undergoing Targeted Biopsy for Evaluation Of Prostate Cancer Versus those on Active Surveillance?
December 1, 2017
SUO 2017: Analysis of External Beam Radiation Therapy, Low-Dose Rate and Combined External Beam with Brachytherapy in Prostate Cancer
December 1, 2017
SUO 2017: Predictors Of Early Disease Specific Mortality Among Patients With Prostate Adenocarcinoma Bone Metastasis At Diagnosis
December 1, 2017
SUO 2017: Utilization of BCG for Non-Muscle Invasive Bladder Cancer in an Era of BCG Supply Shortages
December 1, 2017
SUO 2017: External Validation of EORTC Bladder Cancer Risk Calculator in a Contemporary US Population
December 1, 2017
SUO 2017: Survival Outcomes For African-American Versus Matched Caucasian Patients With mCRPC Treated With Sipuleucel-T
December 1, 2017
SUO 2017: Long Term Outcomes For Patients With Von Hippel Lindau And Pheochromocytoma: Defining The Best Candidates For Active Surveillance
December 1, 2017
SUO 2017: Toward Better Clinical Staging - Molecular Imaging in Muscle Invasive and Metastatic Bladder Cancer
December 1, 2017
SUO 2017: Prostate Cancer Incidence, Treatment Trends, and Survival Among American Indians and Alaskan Natives in The U.S
December 1, 2017
SUO 2017: Neoadjuvant Therapies in Kidney Cancer: Critique, Current Trials and Future Directions
December 1, 2017
SUO 2017: Management of Immune-Related Toxicity with Checkpoint Inhibitors in Bladder Cancer Patients
December 1, 2017
SUO 2017: Metastasis-Free Survival Endpoint
December 1, 2017
SUO 2017: Bladder Cancer: Currently Approved Immunotherapy
December 1, 2017